| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |